Lapointe, H. R., Mwimanzi, F., Cheung, P. K., Sang, Y., Yaseen, F., Speckmaier, S., Barad, E., Moran-Garcia, N., Datwani, S., Duncan, M. C., Kalikawe, R., Ennis, S., Young, L., Ganase, B., Omondi, F. H., Umviligihozo, G., Dong, W., Toy, J., Sereda, P., Burns, L., Costiniuk, C. T., Cooper, C., Anis, A. H., Leung, V., Holmes, D., DeMarco, M. L., Simons, J., Hedgcock, M., Prystajecky, N., Lowe, C. F., Romney, M. G., Barrios, R., Guillemi, S., Brumme, C. J., Montaner, J. S., Hull, M., Harris, M., Niikura, M., Brockman, M. A., & Brumme, Z. L. (2023). antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy. AIDS, 37, 709–721. http://access.bl.uk/ark:/81055/vdc_100180192118.0x000027